SAREPTA THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
SAREPTA THERAPEUTICS, INC. (SRPT) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -179.60% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2026-08-05
- SAREPTA THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, percent for the quarter ending 2026-06-30 was -179.60%, a 736.88% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, percent for the quarter ending 2026-03-31 was 3.60%.
- SAREPTA THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, percent for the quarter ending 2025-09-30 was 7.30%, a 508.33% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, percent for the quarter ending 2025-06-30 was 28.20%, a 235.71% increase year-over-year.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 3 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 6 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 9 month |
|---|---|---|---|
| 2026-06-30 | -179.60% 10-Q · filed 2026-08-05 | 4.50% 10-Q · filed 2026-08-05 | |
| 2026-03-31 | 3.60% 10-Q · filed 2026-05-06 | ||
| 2025-09-30 | 7.30% 10-Q · filed 2025-11-06 | 1.60% 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 28.20% 10-Q · filed 2026-08-05 | 9.00% 10-Q · filed 2026-08-05 | |
| 2025-03-31 | -16.70% 10-Q · filed 2026-05-06 | ||
| 2024-09-30 | 1.20% 10-Q · filed 2025-11-06 | 14.40% 10-Q · filed 2025-11-06 | |
| 2024-06-30 | 8.40% 10-Q · filed 2025-08-06 | 22.60% 10-Q · filed 2025-08-06 | |
| 2024-03-31 | 14.20% 10-Q · filed 2025-05-06 | ||
| 2023-09-30 | -23.40% 10-Q · filed 2024-11-06 | -3.80% 10-Q · filed 2024-11-06 | |
| 2023-06-30 | -2.50% 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | 0.80% 10-Q · filed 2024-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |